L-Carnitine, Immunomodulation, and Human Immunodeficiency Virus (HIV)-related Disorders
β Scribed by Salvatore Alesci; Mariana Gerschenson; Ioannis Ilias
- Publisher
- Springer Vienna
- Year
- 2005
- Tongue
- English
- Weight
- 143 KB
- Volume
- 136
- Category
- Article
- ISSN
- 0026-9247
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have examined preparations of human immunodeficiency virus 1 (HIV-1) and HIV-2 by negative staining electron microscopy. HIV-2 cultures contained large numbers of 130-200 nm particles containing a 130-nm-long by 30-70 nm-wide core. This core is probably of conical or pear-shaped morphology. Some
## Abstract A patient with HIVβrelated immune thrombocytopenic purpura (HIVβITP) had a rapid rise in platelet count when treated with interferonβΞ±2b, 3 million units three times weekly. There were no significant toxicities with therapy. His platelet count fell to pretreatment levels when therapy wa
2',3'-Dideoxy-B-L-cytidine (p-L-ddC), a potent inhibitor against human hepatitis B virus (HBV) and human immunodeficiency virus (HIV), has been stexwsjwifically synthesized from Garabinose in 9 steps. Recently, 2',3'dideoxy-~D-cytidiie (ddC) has been shown to be a potent inhibitor of the replication